PATENT CLAIM ANALYSIS

Application Number: 16075303
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-01
Patent Classification: ["514", "265100"]

Abstract:
The present invention relates to a trifluoroacetate salt of a TLR7 agonist 2-butoxy-7-(4-(pyrrolidin-1-ylmethyl)benzyl)-5H-pyrrolo[3,2-d]pyrimidin-4-amine (formula I), crystalline form B of the trifluoroacetate salt, methods for preparing the trifluoroacetate salt and crystalline form B, and uses of the trifluoroacetate salt and crystalline form B.

Claim (Index 12):
A method for treating Toll-like receptor 7 associated disease, comprising administering to a subject in need thereof the crystal form B according to  claim 3 .

Metadata:
- Claim Count in Document: 1.0
- Percentile: 96.0
- Lexical Diversity: 1.71429
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['16075297', '16310369', '15772995', '15539147', '14976713']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7579704979191325
- 35 USC 102 Novelty (BERT): 0.5197203070020693
- Combined Prediction Score: 0.7341454788274262
- Mean Citation Score: 221.750116
- Max Citation Score: 290.41983
- Similarity Product: 173.0965069145393

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test